Literature DB >> 19083191

Association of the co-stimulator OX40L with systemic lupus erythematosus.

Harinder Manku1, Deborah S Cunninghame Graham, Timothy J Vyse.   

Abstract

The archetypal systemic autoimmune disease systemic lupus erythematosus (SLE) has incompletely understood pathogenesis, although evidence suggests a strong genetic component. Unlike organ-specific autoimmune diseases such as type 1 diabetes, the genetics of lupus are not as dominated by the effect of a single locus. Undoubtedly, the major histocompatibility complex is the greatest and most consistent genetic risk factor in SLE susceptibility; however, recent candidate gene and whole genome association (WGA) studies have identified several other genes that are likely to advance our understanding of this complex disease. One of these, the TNF superfamily member OX40L, interacts with its unique receptor OX40, to maintain T cell memory by providing a late-stage co-stimulatory signal to sustain the survival of activated T cells. The precise immunological consequences are yet to be determined; however, signalling through OX40-OX40L is bidirectional and the reverse signalling pathway via OX40L may quantitatively enhance B cell proliferation to augment the B cell hyperactivity found in SLE. Like OX40L, several genes recently identified in WGA studies are components of B cell pathways. Collectively, these genes will help us to unravel the mechanisms by which aberrant B cell signalling results in lupus pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19083191     DOI: 10.1007/s00109-008-0431-2

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  37 in total

1.  Essential role of OX40L on B cells in persistent alloantibody production following repeated alloimmunizations.

Authors:  Hiroshi Kato; Hidefumi Kojima; Naoto Ishii; Hidenori Hase; Yutaka Imai; Takashi Fujibayashi; Kazuo Sugamura; Testuji Kobata
Journal:  J Clin Immunol       Date:  2004-05       Impact factor: 8.317

Review 2.  Initiation and processing of signals from the B cell antigen receptor.

Authors:  M Reth; J Wienands
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

3.  Signals from OX40 regulate nuclear factor of activated T cells c1 and T cell helper 2 lineage commitment.

Authors:  Takanori So; Jianxun Song; Katsuji Sugie; Amnon Altman; Michael Croft
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-24       Impact factor: 11.205

4.  Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX.

Authors:  Geoffrey Hom; Robert R Graham; Barmak Modrek; Kimberly E Taylor; Ward Ortmann; Sophie Garnier; Annette T Lee; Sharon A Chung; Ricardo C Ferreira; P V Krishna Pant; Dennis G Ballinger; Roman Kosoy; F Yesim Demirci; M Ilyas Kamboh; Amy H Kao; Chao Tian; Iva Gunnarsson; Anders A Bengtsson; Solbritt Rantapää-Dahlqvist; Michelle Petri; Susan Manzi; Michael F Seldin; Lars Rönnblom; Ann-Christine Syvänen; Lindsey A Criswell; Peter K Gregersen; Timothy W Behrens
Journal:  N Engl J Med       Date:  2008-01-20       Impact factor: 91.245

5.  Paradoxical dampening of anti-islet self-reactivity but promotion of diabetes by OX40 ligand.

Authors:  Natalia Martin-Orozco; Zhibin Chen; Laurent Poirot; Elzbieta Hyatt; Andy Chen; Osami Kanagawa; Arlene Sharpe; Diane Mathis; Christophe Benoist
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

Review 6.  Fc receptor genes and the systemic lupus erythematosus diathesis.

Authors:  Elizabeth E Brown; Jeffrey C Edberg; Robert P Kimberly
Journal:  Autoimmunity       Date:  2007-12       Impact factor: 2.815

7.  Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis.

Authors:  A D Weinberg; D N Bourdette; T J Sullivan; M Lemon; J J Wallin; R Maziarz; M Davey; F Palida; W Godfrey; E Engleman; R J Fulton; H Offner; A A Vandenbark
Journal:  Nat Med       Date:  1996-02       Impact factor: 53.440

8.  Identification of novel susceptibility genes in childhood-onset systemic lupus erythematosus using a uniquely designed candidate gene pathway platform.

Authors:  Chaim O Jacob; Andreas Reiff; Don L Armstrong; Barry L Myones; Earl Silverman; Marisa Klein-Gitelman; Deborah McCurdy; Linda Wagner-Weiner; James J Nocton; Aaron Solomon; Raphael Zidovetzki
Journal:  Arthritis Rheum       Date:  2007-12

9.  Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells.

Authors:  E Stüber; M Neurath; D Calderhead; H P Fell; W Strober
Journal:  Immunity       Date:  1995-05       Impact factor: 31.745

10.  In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.

Authors:  Franck J Barrat; Daniel J Cua; André Boonstra; David F Richards; Chad Crain; Huub F Savelkoul; René de Waal-Malefyt; Robert L Coffman; Catherine M Hawrylowicz; Anne O'Garra
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

View more
  8 in total

1.  Gene-gene interaction of BLK, TNFSF4, TRAF1, TNFAIP3, and REL in systemic lupus erythematosus.

Authors:  Xu-jie Zhou; Xiao-lan Lu; Swapan K Nath; Ji-cheng Lv; Sai-nan Zhu; Hai-zhen Yang; Lian-xiang Qin; Ming-hui Zhao; Yin Su; Nan Shen; Zhan-guo Li; Hong Zhang
Journal:  Arthritis Rheum       Date:  2012-01

Review 2.  Genetics of rheumatic disease.

Authors:  Alex Clarke; Timothy J Vyse
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

3.  Dense mapping of IL18 shows no association in SLE.

Authors:  Sandra G Guerra; David L Morris; Vesela Gateva; Robert R Graham; Timothy J Vyse; Deborah S Cunninghame Graham
Journal:  Hum Mol Genet       Date:  2010-12-13       Impact factor: 6.150

4.  OX40/OX40L in systemic lupus erythematosus: association with disease activity and lupus nephritis.

Authors:  Mohamed N Farres; Dina S Al-Zifzaf; Alaa A Aly; Nermine M Abd Raboh
Journal:  Ann Saudi Med       Date:  2011 Jan-Feb       Impact factor: 1.526

5.  Association of TNFSF4 Polymorphisms with Vogt-Koyanagi-Harada and Behcet's Disease in Han Chinese.

Authors:  Sha Lu; Shengfang Song; Shengping Hou; Hua Li; Peizeng Yang
Journal:  Sci Rep       Date:  2016-11-22       Impact factor: 4.379

Review 6.  Abnormal B Cell Development in Systemic Lupus Erythematosus: What the Genetics Tell Us.

Authors:  Sarah Karrar; Deborah S Cunninghame Graham
Journal:  Arthritis Rheumatol       Date:  2018-02-22       Impact factor: 10.995

Review 7.  Developments in the clinical understanding of lupus.

Authors:  Mary K Crow
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

Review 8.  Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity.

Authors:  Yu Fu; Qing Lin; Zhirong Zhang; Ling Zhang
Journal:  Acta Pharm Sin B       Date:  2019-09-03       Impact factor: 11.413

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.